Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
Jump to:
Preferred Name | interferon beta-1a | |
Synonyms |
|
|
ID |
http://purl.obolibrary.org/obo/dinto_DB00060 |
|
activates | ||
AHFScode |
92:00.00
|
|
ATCCode |
L03AB07 L04AA23
|
|
binds | ||
CASRN |
145258-61-3
|
|
DBBrand |
avonex avonex (biogen inc)
|
|
DBSynonym |
interferon beta precursor ifn-beta fibroblast interferon
|
|
Definition |
Human interferon beta (166 residues), glycosylated, MW=22.5kD. It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced. The amino acid sequence of Avonex is identical to that of natural human interferon beta.
|
|
has pharmacological target | ||
label |
interferon beta-1a
|
|
modulates | ||
prefixIRI |
obo2:dinto_DB00060
|
|
prefLabel |
interferon beta-1a
|
|
related with | ||
xref |
National Drug Code Directory:44087-8822-1 GenBank:V00534 UniProtKB:P01574 Wikipedia:http://en.wikipedia.org/wiki/Interferon_beta-1a Drugs Product Database (DPD):2237319 RxList:http://www.rxlist.com/cgi/generic3/rebif.htm Drugs.com:http://www.drugs.com/cdi/interferon-beta-1a.html PharmGKB:PA450037
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping